Trial Profile
Feasibility of "at-Home" Titration of Solifenacin 5 and 10mg and Effect on Symptoms and Quality of Life in a Typical OAB Population.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 27 May 2019
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 29 May 2012 Actual patient number 36 added as reported by ClinicalTrials.gov.
- 29 May 2012 Planned end date changed from 1 Dec 2010 to 1 May 2010 as reported by ClinicalTrials.gov.
- 04 Nov 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.